Sonoma Pharmaceuticals IncNASDAQ:SNOANASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.1500
- TODAY'S CHANGE (%)-0.0066 (-4.2146%)
- Bid / Lots0.1481/ 9
- Ask / Lots0.1550/ 9
- Open / Previous Close0.1480 / 0.1566
- Day Range
- 52 Week Range
- Volume166,482
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SNOA |
|---|---|---|
| 09:32 ET | 6179 | 0.1597 |
| 09:34 ET | 198 | 0.159 |
| 09:52 ET | 610 | 0.156 |
| 09:54 ET | 3170 | 0.1568 |
| 09:56 ET | 129 | 0.155 |
| 09:57 ET | 100 | 0.158 |
| 10:33 ET | 52096 | 0.155 |
| 10:39 ET | 100 | 0.155 |
| 10:46 ET | 2000 | 0.155 |
| 10:48 ET | 100 | 0.155 |
| 10:55 ET | 100 | 0.1549 |
| 11:04 ET | 100 | 0.1549 |
| 11:11 ET | 100 | 0.1549 |
| 11:20 ET | 100 | 0.1549 |
| 11:22 ET | 2500 | 0.1548 |
| 11:27 ET | 100 | 0.1548 |
| 11:29 ET | 108 | 0.1502 |
| 11:36 ET | 100 | 0.1549 |
| 11:44 ET | 100 | 0.1549 |
| 11:51 ET | 105 | 0.154501 |
| 11:54 ET | 100 | 0.1549 |
| 12:03 ET | 100 | 0.1549 |
| 12:14 ET | 100 | 0.1549 |
| 12:23 ET | 100 | 0.1549 |
| 12:30 ET | 10000 | 0.1548 |
| 12:34 ET | 100 | 0.1549 |
| 12:36 ET | 5554 | 0.1549 |
| 12:43 ET | 100 | 0.1549 |
| 12:45 ET | 10100 | 0.154 |
| 12:50 ET | 100 | 0.1549 |
| 12:56 ET | 100 | 0.1549 |
| 01:03 ET | 100 | 0.1549 |
| 01:06 ET | 100 | 0.1549 |
| 01:12 ET | 6229 | 0.151 |
| 01:15 ET | 100 | 0.1549 |
| 01:35 ET | 2700 | 0.154 |
| 01:37 ET | 100 | 0.1539 |
| 01:44 ET | 1000 | 0.1503 |
| 01:48 ET | 100 | 0.1539 |
| 01:51 ET | 1000 | 0.151 |
| 02:00 ET | 100 | 0.1539 |
| 02:08 ET | 100 | 0.1539 |
| 02:20 ET | 100 | 0.1539 |
| 02:22 ET | 1000 | 0.1538 |
| 02:27 ET | 909 | 0.1539 |
| 02:38 ET | 100 | 0.1539 |
| 02:45 ET | 1000 | 0.1515 |
| 02:47 ET | 3000 | 0.1539 |
| 02:49 ET | 1100 | 0.1525 |
| 02:51 ET | 14800 | 0.1539 |
| 02:58 ET | 100 | 0.155 |
| 03:05 ET | 12325 | 0.154 |
| 03:14 ET | 100 | 0.1549 |
| 03:23 ET | 100 | 0.1549 |
| 03:32 ET | 2054 | 0.1517 |
| 03:36 ET | 1515 | 0.15275 |
| 03:41 ET | 100 | 0.15275 |
| 03:45 ET | 6905 | 0.15275 |
| 03:48 ET | 7106 | 0.1515 |
| 03:50 ET | 500 | 0.1515 |
| 03:52 ET | 1740 | 0.1505 |
| 03:54 ET | 100 | 0.1515 |
| 03:56 ET | 100 | 0.154 |
| 03:57 ET | 2886 | 0.1512 |
| 03:59 ET | 712 | 0.15 |
Apr 9, 2024
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States, from 7:32AM ET on Tuesday Apr 09, 2024 by Dow Jones
7:32AM ET on Tuesday Apr 09, 2024 by Dow Jones
Apr 4, 2024
Mar 28, 2024
Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences, from 4:03PM ET on Thursday Mar 28, 2024 by Dow Jones
4:03PM ET on Thursday Mar 28, 2024 by Dow Jones
Mar 27, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sonoma Pharmaceuticals Inc | 2.3M | -0.2x | --- |
Guardion Health Sciences Inc | 10.3M | 64.3x | --- |
GSRX Industries Inc | 16.4K | 0.0x | --- |
CV Sciences Inc | 6.5M | 1.9x | -25.43% |
Evofem Biosciences Inc | 707.5K | 0.0x | --- |
China Pharma Holdings Inc | 4.7M | -0.3x | --- |
Company Information
Sonoma Pharmaceuticals, Inc. is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. The Company's product offerings include Regenacyn Advanced Scar Gel, Regenacyn Plus Scar Gel, Rejuvacyn Advanced Skin Repair Cooling Mist, Pediacyn Skin Care, Microcyn, Ocucyn Eyelid and Eyelash Cleanser, Microdacyn60 Oral Care, Podiacyn Advanced Everyday Foot Care, and MicrocynAH. Regenacyn Advanced Scar Gel helps to improve the overall appearance of scars while reducing pain, itch, redness, and inflammation. Regenacyn Plus is a prescription-strength scar gel which is available as an office dispense product through dermatology practices and medical spas. Pediacyn is a pediatric dermatology and wound care product for over-the-counter use. MicrocynAH is a HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
Contact Information
- Headquarters
- 5445 CONESTOGA COURT, SUITE 150BOULDER, CO, United States 80301
- Phone
- 617-243-0050
- Fax
- 707-283-0551
Executives
- Chief Executive Officer, Director
- Amy Trombly
- Interim Chief Financial Officer
- Jerry Dvonch
- Chief Operating Officer, Corporate Secretary
- Bruce Thornton
- Controller
- John Dal Poggetto
- Lead Independent Director
- Jerry Mclaughlin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3M |
|---|---|
Revenue (TTM) | $12.3M |
Shares Outstanding | 15.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.28 |
EPS | $-0.96 |
Book Value | $1.62 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 0.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -36.06% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
